Partner

Simon Morgan

Languages

English

Simon Morgan is a partner in the Corporate/M&A Team at CMS London. Simon has over 30 years' experience of advising on corporate transactional matters, advising clients across a number of business sectors including Lifesciences, communications and technology.

Clients include established domestic and international companies, public bodies, growing businesses, investment groups and professional intermediaries.

Awards & Recognitions

01 –

Quote

"Simon Morgan is described by one client as "the best corporate lawyer outside the magic circle. He is outstanding and a jewel in the firm’s crown." He is well known for acting on behalf of business in the media sector and "is very wise and has very good judgement"."

Chambers, 2016
Quote

"Simon Morgan is described as an "incredibly knowledgeable, diligent and commercial lawyer who is "at least on a par with the very best lawyers I've worked with," according to one client. He acted for M&C Saatchi on the disposal of a 75.1% stake in Walker Media for GBP 36m"."

Chambers 2015

Relevant experience

Blue Prism, the robotic process automation software business, on its USD 1.65bn recommended offer from SS&C, following the USD 1.5bn recommended offer made for it by US private equity firm, Vista.
M&C Saatchi, the international marketing agency, on its successful defence of the hostile GBP 264m offer made for it by AdvancedAdvT and on the competitive GBP 310m offer made for it by Next15 Communications Group.
BBC Studios, on its GBP 255m acquisition of the ITV Group’s 50% interest in BritBox International, the leading British content TV streamer operating in nine countries.
FremantleMedia Group, on its acquisition of Asacha Media Group, a pan European TV production Group with TV production companies in France, Italy and the UK, on its acquisition of controlling interests in Element Pictures, 72 Films and Wildstar Films and on a series of investments in TV production companies.
BAE Systems on the sale of NetReveal, its financial crime detection business division, to SymphonyAI.
Gigaclear, and its principal shareholder, a fund advised by Infracapital, on an up to GBP 420m equity investment made by funds managed by Equitix.
Rank Group on its GBP 115m offer for online gaming operator, Stride Gaming.
Blue Prism on a GBP 100m equity placing in 2019 and a GBP 100m equity placing in 2020 and Rank Group on a GBP 70m equity placing in 2020.
ParentPay, a leading provider of education technology, on the acquisition by Montagu Private Equity, of a minority interest including the sale by Montagu Private Equity of ESS, an education solutions softare business, to ParentPay.
Syncona, the UK based life science investor, on its investment in a series of life science companies and on the USD 476m sale of Blue Earth Diagnostics, a developer of molecular imaging agents including one involved in the targeting of prostate cancer cells, to Bracco Imaging.
Freeline Therapeutics, a life science company focused on developing curative gene therapies for chronic systemic diseases, on a USD 120m Series C financing including funding from Syncona, Novo Holdings, Eventide Asset Management and Wellington Management Company.
Delancey advised fund, DV4, and management, on the sale of db Symmetry (dbS) to Tritax Big Box REIT valuing dbS at GBP 370m.

Education

1987 – Admitted as a solicitor in England and Wales
1985 - Law Society Finals, England and Wales
1984- MA Law, Pembroke College, Cambridge

Practice Areas

Corporate Equity Capital Markets Mergers & Acquisitions Public Company Takeovers & Mergers

sectors

TMT - Technology, Media & Telecommunications Media

Insights

Global Reach

UK Pay Gap Report 2024

Insights

Global Reach

UK Pay Gap Report 2024

Select your region

Simon Morgan

Languages

Relevant experience

Education

Practice Areas

sectors

Insights by Simon

CMS advises Amber Therapeutics on USD 100m Series A fundraising

CMS advises BBC Studios on the acquisition of ITV’s stake in BritBox

CMS advises Fremantle on the acquisition of Asacha Media Group

CMS advises M&C Saatchi on £310m contested takeover offer